Aperio Group’s XBiotech XBIT Stock Holding History

Aperio Group’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$233K	Buy	14,909 +2,967	+25%	+$54.7K	﹤0.01%	2267
2020 Q3	$228K	Sell	11,942 -4,898	-29%	-$84.5K	﹤0.01%	2186
2020 Q2	$231K	Buy	+16,840	New	+$237K	﹤0.01%	2135

Other funds holding XBIT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CCM

CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Aperio Group's XBIT Position: Q4 2020 in Review

Aperio Group increased its XBiotech (XBIT) stake by 25% in Q4 2020, buying an estimated $54.7K and bringing the position to 14,909 shares worth $233K. The position accounts for ﹤0.01% of the portfolio, ranked #2267.

Aperio Group first reported a position in XBIT in Q2 2020 and has held it in 3 quarters since. 66 funds tracked by Wall St. Rank hold XBIT as of Q4 2020.

Aperio Group held 14,909 shares of XBiotech worth $233K as of Q4 2020.
Aperio Group bought 2,967 XBiotech shares in Q4 2020, an estimated $54.7K.
XBiotech made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #2267 holding.
Aperio Group first reported a position in XBiotech in Q2 2020 and has held it in 3 quarters since.
66 funds tracked by Wall St. Rank held XBiotech as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.